Time stamps
A. Chronic dyspnea
B. Acute cough
C. Subacute cough
D. Chronic cough
A. Chronic dyspnea- >1 month
B. Acute cough- <3 weeks
C. Subacute cough- 3-8 weeks
D. Chronic cough- >8 weeks
Define massive or life-threatening hemoptysis
> 400 mL of blood in 24 h or >150 mL at one time
Risk factors for MRSA and P aeruginosa
prior isolation particularly from the respiratory tract during the preceding year, and/ or hospitalization and treatment with an antibiotic in the previous 90 days
Stages of pneumonia
Initial stage is edema with a proteinaceous exudate and often bacteria in the alveoli
Exudative
Stages of pneumonia
Erythrocytes in the intraalveolar exudate give this stage its name
Red hepatization
Stages of pneumonia
The neutrophil is the predominant cell, fibrin deposition is abundant, and bacteria have disappeared. This phase corresponds with the successful containment of the infection and improvement in gas exchange
Gray hepatization
Stages of pneumonia
the macrophage reappears as the dominant cell in the alveolar space and the debris of neutrophils, and bacteria and fibrin have been cleared, as has the inflammatory response
Resolution phase
This pattern is most common in nosocomial pneumonias
Vs bacterial CAP
Bronchopneumonia pattern- nosocomial
Lobar pattern- bacterial
Typical bacterial pathogens in CAP
S. pneumoniae
Haemophilus influenzae
S. aureus
Klebsiella pneumoniae
P. aeruginosa
Atypical bacterial pathogens in CAP
Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species as well as respiratory viruses such as influenza virus, adenoviruses, human metapneumoviruses, respiratory syncytial virus, and coronaviruses
Pneumonia
They are intrinsically resistant to all Betalactams and require treatment with a macrolide, a fluoroquinolone, or a tetracycline
Atypicals
Risk factors for this pathogen infection include diabetes, hematologic malignancy, cancer, severe renal disease, HIV infection, smoking, male gender, and a recent hotel stay or trip on a cruise ship
Legionella
A 68-year-old man presents with cough, fever, and dyspnea. Chest X-ray shows a right lower lobe pneumonia. On evaluation:
• He is disoriented to time
• Blood pressure: 88/56 mmHg
• Respiratory rate: 32 breaths/min
• BUN: 24 mg/dL
Question:
1. What is his CURB-65 score?
2. What is the recommended site of care?
CURB-65:
• Confusion → +1
• Urea (BUN >7 mmol/L) → +1
• Respiratory rate ≥30 → +1
• Blood pressure (SBP <90 or DBP ≤60) → +1
• Age ≥65 years → +1
👉 Total score: 5
Interpretation / Disposition:
• Score 0–1: Outpatient
• Score 2: Inpatient (ward)
• Score ≥3: Severe pneumonia → ICU admission
Macrolide resistance in S pneumoniae resulting in high level resistance is caused by?
Low level resistance?
ermB gene mutation
mef gene
CA-MRSA isolates tend to be less resistant than the older hospital-acquired strains and are often susceptible to what antibiotics?
trimethoprim-sulfamethoxazole
clindamycin
tetracycline
in addition to vancomycin and linezolid
the most important distinction is that CA-MRSA strains also carry _____
genes for superantigens such as enterotoxins B and C and Panton-Valentine leukocidin
Treatment for CAP LR
Without comorbids
Harrisons:
Amoxicillin 1g + macrolide/doxycycline
OR
Monotherapy with macrolide/doxycycline
CPG 2020:
Amoxicillin 1g TID
OR
Clarithromycin 500mg BID
OR
Azithromycin 500mg OD
Treatment for CAP LR
With comorbids
Harrisons:
Coamoxyclav/cephalosporin + macrolide/doxycycline
OR
Monotherapy respiratory Fluoroquinolones
CPG 2020:
Coamoxyclav/cephalosporin
+/-
macrolide/doxycycline
Treatment for CAP MR
Ampicillin-sulbactam 1.5–3 g every 6 h
OR
Cefotaxime 1–2 g every 8 h
OR
Ceftriaxone 1–2 g daily
+
Macrolide
Treatment CAP HR
1st line:
Ampicillin-sulbactam 1.5–3 g IV every 6 h
OR
Cefotaxime 1–2 g IV every 8 h
OR
Ceftriaxone 1–2 g IV daily
PLUS
Macrolide
Azithromycin 500 mg PO/IV daily
OR
Erythromycin 500 mg PO every 6 hours
OR
Clarithromycin 500 mg PO twice daily
Alternative:
Non-pseudomonal Beta-lactam antibiotic
PLUS
Respiratory fluoroquinolone*
Levofloxacin 750 mg PO/IV daily
OR
Moxifloxacin 400 mg PO/IV daily
* given as 1 hour IV infusion
What strategy can you do to prevent VAP in a patient with altered lower respiratory defenses?
A. Hand washing, especially with alcoholbased hand rub
B. Short course of prophylactic antibiotics for comatose patients
C. selective decontamination of digestive tract with nonabsorbable antibiotics
D. Tight glycemic control
D. Tight glycemic control
the highest hazard ratio for development of VAP?
First 5 days
What is the threshold of growth necessary for diagnosis of pneumonia in a endotracheal aspirate?
Endotracheal aspirate (proximal)- diagnostic threshold is 10^6 cfu/mL
Protected specimen brush (distal)- threshold of 10^3 cfu/mL
Factors indicating the likely need for a procedure more invasive than a thoracentesis (in increasing order of importance) include the following:
LPG GPus